Latest Press Releases

COCO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

PYXS

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Willms and Associates Named Rockford Mutual 2024 Agency of the Year

DDD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD

CRWV

CoreWeave Announces Date of First Quarter 2025 Financial Results

BTCC Exchange Achieves Remarkable Growth in Q1 2025: Record Trading Volume of $815 Billion, Strengthened User Protection, and More User-Centric Initiatives

EXK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK

ZLAB

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025

ADVM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

Dr. Michael Rimlawi Unveils Scholarship for Future Doctors to Support Aspiring Physicians in Shaping Healthcare's Future

Allan Boomer's Momentum Advisors Announces Scholarship for Aspiring Finance and Wealth Management Professionals

TSXV:AQS

Canadian Investment Regulatory Organization Trading Halt - AQS

ALXO

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

Vivienne Westwood dazzles at Barcelona Bridal Night with an epic show

Class Action Filed to Recover Wisconsin Tax Foreclosure Takings

Hyosung Urges Operators of All ATMs to Follow Previous Security Guidance Due to Large-Scale Cyberattacks

Southern California Cities Honor Reproductive Partners Medical Group During National Infertility Awareness Week

AGEN

Agenus' BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

Cash Out On My Home: The Cash Home Buying Company Chattanooga Homeowners Trust to Sell Their House Fast, As-Is, and for a Fair Price

BIDU

Baidu Launches ERNIE 4.5 Turbo, ERNIE X1 Turbo and New Suite of AI Tools to Empower Developers and Supercharge AI Innovation

TSXV:MTN.H

Canadian Investment Regulatory Organization Trading Halt - MTN.H

NewsRamp Partners with PRConnect and Comtex to Boost Press Release Reach and Engagement in a Changing Digital Landscape

NYT Bestselling Relationship Experts Harville Hendrix and Helen LaKelly Hunt Immortalized in New Documentary Film 'The Heart of Dialogue'

Couponasion.com Launches Exclusive French Days 2025 Promo Guide for Bargain Hunters

Direct Response Marketing Agency SeQuel Response Rebrands as Franklin Madison Direct

Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned

Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees

NOC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC

Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

DTE

DTE Completes Construction on Pine River Solar Park

ZYME

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

BOLT

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

NRIX

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

OLMA

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

SAG

SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED

IOBT

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

CDR-Life Presents Promising Preclinical Data for Novel T Cell Engager Programs at AACR Annual Meeting 2025

Marengo to Share Updated Clinical Results from STARt-001 Phase 1/2 Clinical Trial Featuring Invikafusp Alfa Monotherapy Activity in PD1 Resistant Tumors at Upcoming AACR 2025 Clinical Plenary Oral Presentation

RPTX

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Talus Bio Presents Preclinical Data on Transcription Factor Therapeutic Programs at the AACR Annual Meeting 2025